You are here

Article Text

Article menu
Download PDFPDF
Postscript
Letters
Active surveillance of serious adverse drug reactions in New Zealand children
  1. Desiree Kunac1,
  2. Michael V Tatley1,
  3. Keith Grimwood2,
  4. David M Reith3
  1. 1NZ Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
  2. 2Queensland Children's Medical Research Institute, Royal Children's Hospital, University of Queensland, Queensland, Australia
  3. 3Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand
  1. Correspondence to Desiree Kunac, NZ Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago, Dunedin 9054, New Zealand; desiree.kunac{at}otago.ac.nz

https://doi.org/10.1136/archdischild-2011-301457

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Children are at risk of developing adverse drug reactions (ADRs),1 yet few are reported through postmarketing surveillance schemes monitoring safety in this vulnerable population.2 We therefore developed an active surveillance system targeting New Zealand paediatricians to enhance serious ADR notifications in children aged <16 years.

    A priori, paediatricians were given written case definitions of serious ADRs, which …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.